ImmunityBio
IBRX
#3744
Rank
ยฃ1.87 B
Marketcap
ยฃ2.19
Share price
-4.71%
Change (1 day)
-50.66%
Change (1 year)

ImmunityBio (IBRX) - Cash on Hand

Cash on Hand as of December 2024 : ยฃ0.11 Billion

According to ImmunityBio's latest financial reports the company has ยฃ0.11 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ImmunityBio - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.11 B-42.92%
2023-12-31ยฃ0.20 B136.07%
2022-12-31ยฃ88.59 M-62.29%
2021-12-31ยฃ0.23 B233.35%
2020-12-31ยฃ70.47 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ0.19 B 70.86%๐Ÿ‡บ๐Ÿ‡ธ USA